Efficacy and Safety of New and Emerging Drugs for COVID-19: Favipiravir and Dexamethasone.

Shivani SoodGurpreet Kaur BhatiaPrachi SethPawan KumarJagjit KaurVidisha GuptaSandeep PuniaHardeep Singh Tuli

Published in: Current pharmacology reports (2021)

The review describes the path of favipiravir and dexamethasone from chemistry to mechanisms of action to combat SARS-CoV-2. In addition, the potential side effects are also summarized to study their potential to control corona virus 2019.

Keyphrases

sars cov
low dose
high dose
coronavirus disease
respiratory syndrome coronavirus
human health
climate change
drug discovery